MARKET

NOTV

NOTV

Inotiv Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

34.32
+0.61
+1.81%
After Hours: 33.50 -0.82 -2.39% 19:53 09/24 EDT
OPEN
33.32
PREV CLOSE
33.71
HIGH
34.33
LOW
32.72
VOLUME
301.26K
TURNOVER
--
52 WEEK HIGH
50.33
52 WEEK LOW
4.610
MARKET CAP
546.69M
P/E (TTM)
-82.5397
1D
5D
1M
3M
1Y
5Y
Mid-Afternoon Market Update: Dow Surges Over 400 Points; Stitch Fix Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded up 1.28% to 34,353.01 while the NASDAQ rose 1.07% to 14,904.89. The S&P also rose, gaining 1.15% to 4,404.34.
Benzinga · 3d ago
Mid-Day Market Update: Nasdaq Jumps 100 Points; InnovAge Shares Plummet
Midway through trading Wednesday, the Dow traded up 1.01% to 34,261.10 while the NASDAQ rose 0.70% to 14,850.10. The S&P also rose, gaining 0.83% to 4,390.54.
Benzinga · 3d ago
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products...
Benzinga · 3d ago
Aethlon Medical, Onconova Therapeutics leads healthcare gainers; ReWalk Robotics, InnovAge among major losers
Gainers: Aethlon Medical (NASDAQ:AEMD) +36%, Onconova Therapeutics (NASDAQ:ONTX) +35%, Dynavax Technologies (NASDAQ:DVAX) +23%, Candel Therapeutics (NASDAQ:CADL) +22%, BioCardia (NASDAQ:BCDA) +11%. Losers: ReWalk Robotics (NASDAQ:RWLK) -27%, InnovAge (NASD...
Seekingalpha · 3d ago
Top Midday Decliners
MT Newswires · 3d ago
Insiders of Inotiv, Inc. (NASDAQ:NOTV) reaped rewards after their US$608k investment jumped another US$1.0m
Inotiv, Inc. ( NASDAQ:NOTV ) insiders who bought shares over the past year were rewarded handsomely last week. The...
Simply Wall St. · 3d ago
BRIEF-Inotiv Announces Proposed Convertible Senior Notes Offering
reuters.com · 4d ago
Why Inotiv's Stock Is Trading Higher Today
Inotiv (NASDAQ:NOTV) shares are trading higher after the company announced it will purchase Envigo for $200 million of cash and 9,365,173 Inotiv common shares.
Benzinga · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NOTV. Analyze the recent business situations of Inotiv Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NOTV stock price target is 64.50 with a high estimate of 72.00 and a low estimate of 57.00.
EPS
Institutional Holdings
Institutions: 76
Institutional Holdings: 6.91M
% Owned: 43.43%
Shares Outstanding: 15.93M
TypeInstitutionsShares
Increased
20
1.85M
New
39
2.12M
Decreased
6
140.08K
Sold Out
9
159.56K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.13%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Non-Executive Chairman/Independent Director
Gregory Davis
President/Chief Executive Officer/Director
Robert Leasure
Chief Financial Officer/Vice President - Finance/IR Contact Officer
Beth Taylor
Chief Operating Officer
John Beattie
Chief Human Resource Officer
William Pitchford
Senior Vice President
Philip Downing
Senior Vice President
Gopala Krishna
Vice President
Andrew Alexander
Vice President
Daniel Smeak
Vice President
Kenneth Swart
Other/Director
John Sagartz
Independent Director
Richard Johnson
Independent Director
R. Matthew Neff
No Data
About NOTV
Inotiv, Inc, formerly Bioanalytical systems, Inc., is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: research services and research products. The research services segment provides research and development support on a contract basis directly to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. The Company supports both the non-clinical and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, but also including biotherapeutics and devices.

Webull offers kinds of Inotiv Inc stock information, including NASDAQ:NOTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NOTV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NOTV stock methods without spending real money on the virtual paper trading platform.